₹ 0.6 Cr
Volume Transacted
(Nov 22, 2024)
4.8 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
Emcure Pharmaceuticals Ltd
NSE: EMCURE
YEARLOW
₹ 1226.5
Last updated on: Nov 22, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 1313.6 | 1286.15 | 1334 | 1286.15 |
21 Nov 2024 | 1284.2 | 1329.95 | 1329.95 | 1278.6 |
19 Nov 2024 | 1306.05 | 1312.1 | 1334.35 | 1290 |
18 Nov 2024 | 1310.5 | 1335.15 | 1355.3 | 1295.05 |
14 Nov 2024 | 1358.75 | 1345.5 | 1382 | 1345.5 |
13 Nov 2024 | 1333.85 | 1403 | 1410 | 1328.6 |
12 Nov 2024 | 1399.15 | 1441.2 | 1448 | 1394.45 |
11 Nov 2024 | 1432.65 | 1429.8 | 1465 | 1399.8 |
08 Nov 2024 | 1396.85 | 1498.95 | 1523.8 | 1380.1 |
07 Nov 2024 | 1437.35 | 1440 | 1456 | 1425 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 1313.6 |
21 Nov 2024 | 1284.2 |
19 Nov 2024 | 1306.05 |
18 Nov 2024 | 1310.5 |
14 Nov 2024 | 1358.75 |
13 Nov 2024 | 1333.85 |
12 Nov 2024 | 1399.15 |
11 Nov 2024 | 1432.65 |
08 Nov 2024 | 1396.85 |
07 Nov 2024 | 1437.35 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Emcure Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Emcure Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Emcure Pharmaceuticals allots 3.33 lakh equity shares under ESOS
Emcure Pharmaceuticals has allotted 3,33,500 equity shares under ESOS on 22 November 2024....
22 Nov 202417:56
Emcure Pharma Q2 PAT rises 38.2% YoY
In Q2FY25, the drug maker's consolidated revenue from operations stood at Rs 2,002 crore, ...
08 Nov 202412:50
Emcure Pharmaceuticals to hold board meeting
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...
02 Nov 202413:58
Emcure Pharmaceuticals to announce Quarterly Result
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...
31 Oct 202410:43
Emcure signs licensing agreement with Gilead Sciences
Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...
03 Oct 202410:15
Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities
Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigne...
13 Aug 202419:01
Unlimited trading at just
Rs. 199*